Dipyridamole technetium 99m sestamibi myocardial tomography for preoperative cardiac risk stratification before major or minor nonvascular surgery

American Heart Journal

Volumn 132, Issue 3, 1996, Pages 536-541

  Stratmann, Henry G ^a,b   Younis, Liwa T ^a   Wittry, Mark D ^a   Amato, Maryellen ^a   Mark, Alexander L ^a   Miller, D Douglas ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; FEMALE; GENERAL SURGERY; HEART DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SUDDEN DEATH; UNSTABLE ANGINA PECTORIS;

EID: 0029970716     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90235-5     Document Type: Article

References (30)

1. Goldman L, Caldera DL, Nussbaum SR, Southwick FS, Krogstad D, Murray B, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845-50.
2. Gersh BJ, Rihal CS, Rooke TW, Ballard DJ. Evaluation and management of patients with both peripheral vascular and coronary artery disease. J Am Coll Cardiol 1991;18:203-14.
3. Detsky AS, Abrams HB, McLaughlin JR, Drucker DJ, Sasson Z, Johnston N, et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1986;1:211-9.
4. Zeldin RA, Math B. Assessing cardiac risk in patients who undergo noncardiac surgical procedures. Can J Surg 1984;27:402-4.
5. Eagle KA, Coley CM, Newell JB, Brewster DC, Darling RC, Strauss HW, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989;110:859-66.
6. Lette J, Watters D, Lassonde J, Rene P, Picard M, Laurendeau F, et al. Multivariate clinical models and quantitative dipyridamole-thallium imaging to predict cardiac morbidity and death after vascular reconstruction. J Vasc Surg 1991;14:160-9.
7. Younis LT, Aguirre F, Byers S, Dowell S, Barth G, Walker H, et al. Perioperative and long-term prognostic value of intravenous dipyridamole thallium scintigraphy in patients with peripheral vascular disease. Am Heart J 1990;119:1287-92.
8. Hendel RC, Layden JJ, Leppo JA. Prognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart disease. J Am Coll Cardiol 1990;15:109-16.
9. McEnroe CS, O'Donnell TF, Yeager A, Konstam M, Mackey WC. Comparison of ejection fraction and Goldman risk factor analysis to dipyridamole-thallium 201 studies in the evaluation of cardiac morbidity after aortic aneurysm surgery. J Vasc Surg 1990;11:497-504.
10. Marwick TH, Underwood DA. Dipyridamole thallium imaging may not be a reliable screening test for coronary artery disease in patients undergoing vascular surgery. Clin Cardiol 1990;13:14-8.
11. Lette J, Waters D, Cerino M, Picard M, Champagne P, Lapointe J. Preoperative coronary artery disease risk stratification based on dipyridamole imaging and a simple three-step, three-segment model for patients undergoing noncardiac vascular surgery or major general surgery. Am J Cardiol 1992;69:1553-8.
12. Baron JF, Mundler O, Bertrand M, Vicaut E, Barre E, Godet G, et al. Dipyridamole-thallium scintigraphy and gated readionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med 1994;330:663-9.
13. L'Italien GJ, Cambria RP, Cutler BS, Leppo JA, Paul SD, Brewster DC, et al. Comparative early and late cardiac morbidity among patients requiring different vascular surgery procedures. J Vasc Surg 1995;21:935-44.
14. Coley CM, Field TS, Abraham SA, Boucher CA, Eagle KA. Usefulness of dipyridamole-thallium scanning for preoperative evaluation of cardiac risk for nonvascular surgery. Am J Cardiol 1992;69:1280-5.
15. Brown KA, Rimmer J, Haisch C. Noninvasive cardiac risk stratification of diabetic and nondiabetic uremic renal allograft candidates using dipyridamole-thallium-201 imaging and radionuclide ventriculography. Am J Cardiol 1989;64:1017-21.
16. Camp AD, Garvin PJ, Hoff J, Marsh J, Byers SL, Chaitman BR. Prognostic value of intravenous dipyridamole thallium imaging in patients with diabetes mellitus considered for renal transplantation. Am J Cardiol 1990;65:1459-63.
17. Younis L, Stratmann H, Takase B, Byers S, Chaitman BR, Miller DD. Preoperative clinical assessment and dipyridamole thallium-201 scintigraphy for prediction and prevention of cardiac events in patients having major noncardiovascular surgery and known or suspected coronary artery disease. Am J Cardiol 1994;74:311-7.
18. Sochor H. Technetium-99m sestamibi in chronic coronary artery disease: the European experience. Am J Cardiol 1990;66:91-6E.
19. Taillefer R. Technetium-99m sestamibi myocardial imaging: same-day rest-stress studies and dipyridamole. Am J Cardiol 1990;66:80-4E.
20. Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Miller DD. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. Am J Cardiol 1994;73:647-52.
21. Stratmann HG, Tamesis BR, Younis LT, WittryMD, Amato ME, Miller DD. Prognostic value of predischarge dipyridamole technetium-99m sestamibi myocardial tomography in medically treated patients with unstable angina. Am Heart J 1995;130:734-40.
22. Stratmann HG, Younis LT, Wittry MD, Amato ME, Miller DD. Dipyridamole technetium-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery: prognostic value for perioperative and late cardiac events. Am Heart J 1996;131:923-9.
23. Maddahi J, Kiat H, Van Train KF, Prigent F, Friedman J, Garcia EV, et al. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease. Am J Cardiol 1990;66:55-62E.
24. Brown KA, Prognostic value of thallium-201 myocardial perfusion imaging: a diagnostic tool comes of age. Circulation 1991;83:363-81.
25. Lette J, Waters D, Lapointe J, Gagnon A, Picard M, Cerino M, et al. Usefulness of the severity and extent of reversible perfusion defects during thallium-dipyridamole imaging for cardiac risk assessment before noncardiac surgery. Am J Cardiol 1989;64:276-81.
26. Hendel RC, Whitfield SS, Villegas BJ, Cutler BS, Leppo JA. Prediction of late cardiac events by dipyridamole thallium imaging in patients undergoing elective vascular surgery. Am J Cardiol 1992;70: 1243-9.
27. Kiat H, Maddahi J, Roy LT, Van Train K, Friedman J, Resser K, et al. Comparison of technetium 99m methoxy isobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989;117:1-11.
28. McFalls EO, Doliszny KM, Grund F, Chute E, Chesler E. Angina and persistent exercise thallium defects: independent risk factors in elective vascular surgery. J Am Coll Cardiol 1993;21:1347-52.
29. Rocco TP, Dilsizian V, McKusick KA, Fischman AJ, Boucher CA, Strauss HW. Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium. Am J Cardiol 1990;66:158-63.
30. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323:141-6.